| Views | |
|---|---|
| ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | 157 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | 5 | 6 | 18 | 18 | 8 | 4 | 1 |
| Views | |
|---|---|
| EMBR_EMBR202154305.pdf | 182 |
